ResearcherChinese University of Hong KongActive in the last 2 years

Tianli Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-7816-2851; OpenAlex author ID A5011133719. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2026: 1 paper

Papers 1

Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment. Co-author DOI 10.1002/advs.76575 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xin Wang · 1 shared paper, 2026 · strength 0.25
- Paper Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment. DOI 10.1002/advs.76575 ↗
Hang Jiang · 1 shared paper, 2026 · strength 0.25
- Paper Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment. DOI 10.1002/advs.76575 ↗
Ajay Goel · 1 shared paper, 2026 · strength 0.25
- Paper Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment. DOI 10.1002/advs.76575 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.